Ignite Creation Date:
2025-12-25 @ 1:43 AM
Ignite Modification Date:
2026-03-03 @ 6:47 PM
Study NCT ID:
NCT01867294
Status:
COMPLETED
Last Update Posted:
2020-01-09
First Post:
2012-08-27
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Spironolactone in Preventing Rash in Patients With Advanced Cancer Receiving Panitumumab and Cetuximab
Sponsor:
Academic and Community Cancer Research United
Organization: